Sanofi’s Jevtana® (cabazitaxel) Not Obvious over Docetaxel Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC (Fed. Cir. 2019) CAFC Panel: Circuit Judges Lourie, Moore, and Taranto Opinion by Circuit Judge Lourie See Patent Doc’s Post: https://www.patentdocs.org/2019/08/sanofi-aventis-us-llc-v-dr-reddys-laboratories-inc-fed-cir-2019.html https://www.jevtana.com/ Share: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Click to print (Opens in new window) Print